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ABSTRACT 
Optoacoustic Tomography (OT) is now widely used in preclinical imaging, however, 
precision (repeatability and reproducibility) of OT has yet to be determined.  
Methods: We used a commercial small animal OT system. Measurements in stable 
phantoms were used to independently assess the impact of system variables on 
precision (using coefficient of variation, COV), including acquisition wavelength, 
rotational position, frame averaging. Variables due to animal handling and 
physiology, such as anatomical placement and anesthesia conditions were then 
assessed in healthy nude mice using the left kidney and spleen as reference organs. 
Temporal variation was assessed by repeated measurements over hours and days 
both in phantoms and in vivo. Sensitivity to small molecule dyes was determined in 
phantoms and in vivo; precision was assessed in vivo using IRDye800CW.   
Results: OT COV in a stable phantom was less than 2% across all wavelengths over 
30 days. The factors with greatest impact on the signal repeatability in phantoms 
were rotational position and user experience, both of which still resulted in a COV of 
less than 4%. Anatomical region of interest size showed the highest variation at 12% 
and 18% COV in the kidney and spleen respectively, however, functional SO2 
measurements based on a standard operating procedure showed exceptional 
reproducibility of <4% COV. COV for repeated injections of IRDye800CW was 6.6%. 
Sources of variability for in vivo data included respiration rate, user experience and 
animal placement. 
Conclusions: Data acquired with our small animal OT system was highly repeatable 
and reproducible across subjects and over time. Therefore, longitudinal OT studies 
may be performed with high confidence when our standard operating procedure is 
followed. 
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INTRODUCTION 
Optoacoustic Tomography (OT) is a fast developing imaging modality, 
combining the high resolution and penetration depth of ultrasound detection with the 
high contrast available from optical absorption in tissue (1). Endogenous optical 
absorption provides structural and functional imaging information (2,3), while the 
introduction of exogenous contrast agents in vivo enables molecular imaging (4,5) for 
example, by targeting specific cell receptors (6) or enzymatic processes (7). Given 
that OT is finding widespread application in preclinical imaging (8) and has potential 
for rapid clinical translation (1), technical validation assessing both accuracy and 
precision (9,10) is now vital.  
To date, technical validation of OT has focused on accuracy, using light 
fluence models to enable quantitative determination of absorption coefficients (11). 
There is a paucity of data on precision, which can considered as measurement 
repeatability, with the same subject or user, and reproducibility, with independent 
subjects or users. Precision is often characterized by the coefficient of variation 
(COV), which has been assessed to a limited extent for OT in phantoms (12), but not 
in vivo, where animal handling and physiology significantly impact results (8). High 
intra-subject COV limits the applicability of a modality for longitudinal imaging 
studies, whereas high inter-subject COV would modify study design (e.g. requiring 
that each animal serve as their own control). Here, we developed and applied a 
framework for evaluating precision of OT systems in phantoms and living subjects. 
Our results show that precision of the OT system tested compares favorably with 
existing preclinical imaging modalities and hence could be reliably applied in 
biomedical research. 
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MATERIALS AND METHODS 
Optoacoustic tomography system 
A number of commercial small animal optoacoustic systems are now 
available (13). In this study, we used a MultiSpectral Optoacoustic Tomography 
(MSOT) system (inVision256-TF; iThera Medical) described in detail elsewhere 
(14,15). Briefly, a tunable (660–1300nm) optical parametric oscillator pumped by an 
Nd:YAG laser provides 9ns excitation pulses at 10Hz repetition rate. Ten arms of a 
fiber bundle illuminate a ring of ~8mm width at the sample, with fluence below the 
maximum permissible exposure according to ANSI Z136.1 over the wavelength 
range investigated (Supplemental Fig. 1). Laser energy is recorded for each pulse 
and the acoustic signal is divided by this value prior to saving. The sample is 
mounted in a motorized holder for linear translation in the z-direction over a range of 
<150mm (Fig. 1A). Coupling of the sample to the transducers is achieved using a 
water bath, filled with degassed, deionized water. For ultrasound detection, 256 
toroidally focused ultrasound transducers specified at 5MHz center frequency, 60% 
bandwidth, are organized in a concave array with 270 degree angular coverage and 
a radius of curvature of 4 cm.  
Framework for evaluating precision of preclinical optoacoustic tomography 
 For preclinical imaging in small animals, evaluation of precision should be 
made separately across anatomical (e.g. tumor volume), functional (e.g. 
oxygenation) and molecular (e.g. tracer uptake) parameters. Firstly, to account for 
system variation, the precision of the imaging data in phantoms should be assessed 
across all acquisition variables (e.g. wavelengths, rotational positions, averaging, 
time). Secondly, the precision across living subjects should be assessed while 
following a standard operating procedure (SOP). Measurements should be taken by 
different users to evaluate the impact of user experience and animal handling. 
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Finally, for contrast agent studies, sensitivity to the contrast agent of interest should 
be determined in addition to precision, to ensure accurate decisions on the dose of 
agent to be used in vivo. Details of standard operating procedures for all experiments 
presented are given in the Supplemental Note. 
     Precision evaluation in phantoms and in vivo. A commercial stable polyurethane 
phantom (fabricated by Computerized Imaging Reference Systems Inc., supplied by 
iThera Medical) with a diameter of 2cm and sound speed of 1430ms-1 was employed 
for phantom studies of repeatability. The acoustic attenuation of the phantom is given 
as 0.5 dB/cm/MHz. Using a commercial stable phantom avoids drift in measurements 
due to matrix degradation and enables users of other systems to replicate our study. 
The phantom bulk is composed of a purely scattering matrix, within which are 
contained absorbing calibration targets. The phantom was clamped into the supplied 
rigid phantom holder, which ensures repeatable positioning, and placed into the 
imaging chamber of the MSOT system (Fig. 1B). Following equilibration of phantom 
temperature with the 36°C water bath for 10min, imaging was performed over 5 scan 
positions covering the calibration targets in 1mm steps. Images were acquired at 
660nm and from 700–1100nm in 50nm steps. The repeatability in longitudinal studies 
was measured over the course of 6 hours, 1 day, and 1 month. Data is shown at 
700nm in all cases, with other wavelengths detailed in Supplemental Table 1. 
We used the same phantom to investigate the effects of sample rotation and 
frame averaging. Sample rotation was assessed due to the incomplete acoustic 
sampling of the system geometry. We acquired data as above with the phantom 
rotated by 0, 90, 180 and 270 degrees with respect to its long axis between 
measurements. To test the impact of frame averaging, we recorded up to 100 frames 
and averaged either the reconstructed image frames (sequential) or the raw acoustic 
signals (continuous), available as options within the acquisition software. Given the 
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use of a rigid holder for phantom imaging, the effect of different operators on 
phantom data acquisition was not explored. 
Procedures in small animals were carried out under the authority of project 
and personal licenses issued by the Home Office, UK and were approved by local 
Animal Welfare and Ethical Review Bodies. Healthy BALB/c nude mice (Charles 
River) aged between 8 and 12 weeks were housed in techniplast green line 
individually ventilated  cages with APB6 bedding on a 12 hours on/off light/dark cycle 
(7am to 7pm) with 5R58 diet.  
Mice were anesthetized using inhaled isoflurane mixed with 100% oxygen 
and placed supine into the animal holder (Fig. 1B). A flexible polyethylene membrane 
surrounded the mouse forming a watertight seal, with anesthesia supplied via a gas 
inlet. A thin layer of clear ultrasound gel (Aquasonics, Parker) applied with a spatula 
was used to couple the skin of the mouse to the membrane. Mouse preparation took 
~15min. Ultrasound gel was centrifuged to remove air bubbles and warmed prior to 
application. Following equilibration of mouse temperature with the 36°C water bath 
for 12min (previously determined by rectal probe), imaging was performed in a single 
slice centered on the kidneys and spleen. Images were acquired between 690nm 
and 880nm in 10nm steps, with 10 averages (continuous averaging).  
The influence of inhaled isoflurane concentration (1.2–3%) on respiration rate 
(40–140 bpm) and the resulting SO2MSOT measurements was first determined in a 
subset of animals (n=3), after which respiration was maintained at 60-70bpm with 
(1.75±0.25)% isoflurane for the remainder of the studies. For full COV calculations, 
we then examined: continuous imaging over 90min; acquisition of 6 image frames 
leaving the mouse in the same position (without replacement, n=7 mice) or removing 
and immediately replacing the mouse before each acquisition (with replacement, 
subset of n=4 mice); and repeated imaging over 3 days (with replacement). Given 
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that variability is expected in the handling and placement of the mice, data acquired 
by two independent users was also analyzed.  
     Sensitivity and precision for detecting small molecule dyes in phantoms and in 
vivo. To assess the detection sensitivity for small molecule dyes, phantoms with 
defined optical properties that closely mimic biological tissue were fabricated. 
Phantom absorption and reduced scattering coefficients followed the ‘generic tissue’ 
definition given by Jacques (16) and are shown in Supplemental Figure 2. All 
chemicals were purchased from Sigma Aldrich unless otherwise stated. Pre-warmed 
intralipid was added to liquid agar to provide scattering and nigrosin dye to provide 
absorption. The solution was poured into a 20mL syringe (2cm diameter) containing 
a 3D printed plastic mold to create a cylindrical hole of 3mm diameter at the phantom 
center, into which a sealed thin walled plastic straw containing a solution of dye was 
inserted. Commercially available small molecule dyes (relevant to clinical use) were 
used: IRDye 800CW (IR800, Licor), indocyanine green (ICG) and methylene blue 
(MB). IR800 and MB were dissolved in phosphate buffered saline while ICG was 
dissolved in water due to the poor solubility in phosphate buffered saline. The tissue 
mimicking phantom was placed into the MSOT system using the procedure 
described for small animal imaging. The water bath temperature was set to 34°C to 
prevent loss of structural integrity of the agar. Images were acquired at multiple 
wavelengths at 5 scan positions with a 1mm step size.  
To assess in vivo detection sensitivity and precision, we prepared mice (n=3) 
for imaging (as above) but also inserted a tail vein catheter with a dead volume of 
35µL. Under terminal anesthesia (n=2), we performed a dose escalation study, 
injecting 135µL of 2, 4, 8, 20 and 50µM IR800 dissolved in phosphate buffered saline 
at 11 min intervals. In a separate animal, we then repeatedly injected 135µL of 8µM 
IR800 at 16 min intervals. The narrow time intervals between injections mean that 
the dye will not have fully cleared from the bloodstream; we therefore calculated the 
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intensity difference before and after injection, rather than comparing absolute 
intensities. Images were acquired continuously (at the dye specific excitation 
wavelengths) in order to observe dynamics in vivo. 
Image and statistical analysis 
Images were reconstructed offline and analyzed using the ViewMSOT 
software package (v3.6; iThera Medical). The model-linear based reconstruction and 
linear regression multispectral processing tools were used (17,18). The 
reconstruction algorithm includes by default an electrical impulse response 
correction, which accounts for the Gaussian response of the ultrasound transducers 
by deconvolving a reference impulse response from the measured acoustic signals. 
The reference impulse response is based on the vendor specifications for transducer 
performance, the key parameters of which (5MHz center frequency, 60% bandwidth) 
were verified by the manufacturer of the supplied transducer array using pulse-echo 
ultrasound. For the phantom rotation studies, images were reconstructed with and 
without the impulse response. The same speed of sound (adjusted manually) was 
used for all image reconstructions within a given data set.  
Mean pixel intensity and standard deviation values were extracted from 
regions of interest (ROIs). For stable phantom studies, the ROI size (12.3mm2) and 
position were identical across all data sets (Fig. 1C) and single wavelength images 
were used for analysis. For tissue mimicking phantoms, the ROI size (6.15mm2) was 
identical across all data sets but the position was optimized between images; both 
single wavelength and multispectral images were used. For small animal studies, 
ROIs were drawn around the left kidney and the spleen (Fig. 1C) in each mouse. 
When IR800 was injected, ROIs were drawn around the right kidney, to avoid any 
confounding influence of light attenuation by the spleen.  
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Linear regression with published spectra for oxy- (HbO2) and deoxy-
hemoglobin (Hb), as well as IR800 (19,20), was used to produce images in arbitrary 
units that indicate the relative weight that each spectrum contributes to a given image 
pixel. Oxygen saturation was extracted as the ratio of ROI data from the HbO2- and 
Hb- weighted images and calculated as HbO2/(Hb+HbO2). OT is only able to 
accurately resolve absolute SO2 if the recorded signal can be related to the absorbed 
optical energy distribution, which requires knowledge of the light fluence distribution, 
system response and Grueneisen parameter (11); as we do not have this 
information, our image intensities are given in arbitrary units and we denote the 
oxygenation metric derived in this study as SO2MSOT. Total hemoglobin (THb) was 
extracted as (Hb+HbO2), hence is given in arbitrary units. 
COVs were calculated from raw data extracted from ROIs as the ratio of the 
standard deviation to the mean, expressed as a percentage. Signal-to-noise ratio 
(SNR) was calculated as the ratio of the signal ROI mean to the background ROI 
standard deviation. Signal-to-background ratio was calculated as the ratio of the 
signal ROI mean to the background ROI mean. Uncertainty on mean values is 
represented by the standard error unless otherwise stated. Statistical analysis was 
performed in Origin (OriginLab Corp.). 
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RESULTS 
Precision evaluation in phantoms 
The temporal repeatability of the optoacoustic tomography system across all 
wavelengths assessed with a commercial stable polyurethane phantom was 
excellent (Supplemental Table 1). No significant drift was seen in the mean pixel 
intensity during continued acquisition over 160min (Fig. 2A), nor over the course of 
6h (Fig. 2B). The COV at 700nm over 6h was 0.5% without replacement (phantom 
remaining in the system for the full 6h), rising to 1.2% with replacement (phantom 
removed between data acquisitions). Over 30 days (with replacement, Fig. 2C) we 
found a COV of just 1.9% with a minor system drift of <0.2%. The laser energy for all 
short term repeatability studies was stable (Supplemental Fig. 3A-C). A decrease in 
energy was observed over 30 days (Supplemental Fig. 3D), as would be expected 
from gradual contamination of the optics, in particular the optical parametric 
oscillator. When a user with no ROI drawing experience was asked to conduct the 
task (compared to 2 years experience for the main user), COV for 6h rose to 1.3% 
and 3.8% without and with replacement respectively and COV over 30 days rose to 
3.1%.  
We also established the influence of sample rotational position and image 
averaging. The 0° and 180° rotations are located within similar view fields of the 
transducer array, whereas the 90° rotation is likely to be less well captured than the 
270° rotation due to the limited bandwidth and field of view of the ultrasound 
transducers, as confirmed by images reconstructed without the correction (Fig. 3A). 
Electrical impulse response correction of the raw data reduced the COV due to 
rotation from 13.4% (Fig. 3B) to 3.6% (Fig. 3C) and almost doubled the image SNR 
(from 46.1 to 91.5). Although our transducer array meets design specifications within 
tolerances, the transducers that capture the left hand side of the image have a 
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tendency towards higher center frequency and bandwidth (manufacturer certificate of 
conformance). This results in an overamplification of the 0° rotation compared to 
180° after correction (Fig. 3C). The improved representation of low frequencies 
(where the field of view of the individual transducers is much wider) results in an 
overall increase in the mean pixel intensity after correction and more comparable 
data at the 90° and 270° rotations.  
For image averaging, the sequential method (averaging of multiple 
reconstructed image frames, Supplemental Fig. 4A) increased SNR but continuous 
(direct averaging of the acoustic signals, Supplemental Fig. 4B) did not. This is likely 
due to the fact that the acoustic signal averaging smooths the raw pressure signals 
so does not account for all factors that influence the noise in the final reconstructed 
image. These data illustrate the trade-off between SNR, which was optimal with >25 
averages (Supplemental Fig. 4A), and acquisition time, which was >25s per data set 
with this number of averages.  
As a preliminary assessment of the generalizability of these precision 
measurements, we also acquired images of the commercial phantom using a non-
tomographic optoacoustic system, which uses a light emitting diode array for signal 
excitation and a linear ultrasound transducer array for detection (Supplemental Fig. 
5A). The acquired data indicated that the same commercial phantom could be 
successfully used in a different geometry. Measured COVs were 13.9% and 6.1% 
over 160min and 6h respectively (Supplemental Fig. 5B,C); these higher values 
relative to the OT system could be due to heating of the excitation light source and 
water coupling medium over time. 
Precision evaluation in vivo 
Given the impact of animal handling and physiology on in vivo imaging data, 
we established the precision of our OT system in living subjects using the left kidney 
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and spleen as reference organs. All ROIs were drawn by an experienced (>1 year) 
user unless otherwise stated. Considering first anatomical size data, the left kidney 
and spleen had average ROI areas of (21.0±0.7)mm2 (COV 12%) and (19.2±1.0)mm2 
(COV 18%) respectively over all mice (n=13). When ROIs were independently drawn 
in repeated frames of individual mice, the average COVs were 4.4±1.2% and 
7.3±0.7% for the kidney and spleen (n=8), increasing to 6.1±1.1% and 10.4±1.5% 
respectively with replacement between acquisitions (n=7). For the following studies 
we used a fixed ROI size and shape for each mouse, copying into repeated image 
frames and allowing adjustments in orientation to position the ROI on the organ. 
Having established the precision of anatomical size data, we then moved on 
to functional data. Example images of Hb and HbO2 are shown in Supplemental Fig. 
6. We noted that ROI data extracted from the Hb and HbO2 images directly, as well 
as their sum (THb) showed a high COV <18.5% between mice (reproducibility); the 
ratiometric readout SO2MSOT showed a much lower COV with <4% variation (Table 1). 
We attributed the high variation in Hb, HbO2 and THb metrics to inherent biological 
variation between mice, which appears to be minimized by taking the ratio, hence we 
used SO2MSOT as our OT biomarker for temporal COV calculations. We also noted 
that changing the isoflurane anesthetic concentration in the range 1.2–3% over 
10mins (associated respiration rate range 40–140 bpm) resulted in >30% decrease 
in spleen SO2MSOT and >9% decrease in the kidney (p=0.047, 0.043 respectively by 
paired two-tailed t-test; n=3). For the temporal studies, we therefore maintained all 
mice using isoflurane anesthetic concentration (1.75±0.25)% (respiration rate range 
60-70bpm) during imaging to minimize variation. 
Temporal repeatability in vivo was assessed over 90mins (one continuous 
acquisition) then during 6 consecutive acquisitions on one day (with and without 
replacement) and over 3 days. COVs are calculated for the ratiometric SO2MSOT 
measurement; THb is shown for comparison. We observed a drift in SO2MSOT and 
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THb over 90mins (Fig. 4A), but for repeated measurements, we found excellent 
longitudinal repeatability over 6 acquisitions within the same day (Fig. 4B). While this 
remained true for SO2MSOT over 3 days, it was not the case for THb (Fig. 4C). Since 
the animal holder is not rigid, we examined the impact of replacement and also of 
different users. Replacement of the mouse between sequential acquisitions led to a 
COV of <1.4% compared to <0.6% without replacement (Table 2). A less 
experienced user (acquisition and ROI drawing performed in fewer than 10 mice) 
resulted in only a marginally higher COV (<0.8%). One-way repeated measures 
ANOVA performed for the left kidney and spleen, SO2MSOT and THb, indicated that 
replacements had no significant influence on the variation (p>0.27) but individuals 
were significantly different (p<0.0001). Over 3 days, neither replacements (p>0.09) 
nor individuals (p>0.47) were significant. Overall COV in SO2MSOT was <1% for 
repeatability and <4% for reproducibility. 
Sensitivity for small molecule dyes in phantoms and in vivo 
Detection limits were determined to be 100nM for IR800 (Supplemental Fig. 
7A) and ICG (Supplemental Fig. 7B) and 5µM for MB (Supplemental Fig. 7C); 
equivalent optical density values were 0.10 (IR800, 777nm), 0.084 (ICG, 778 nm) 
and 0.17 (MB, 664 nm) respectively. Considering the volume of dye present within an 
image slice (determined by the transducer focus as approximately 6.16µL), this is 
equivalent to ~0.62pmol for IR800 and ICG, and ~30.8pmol for MB. The higher 
threshold for MB may be explained by the smaller extinction coefficient higher 
background absorption at its peak wavelength. The absorption spectra 
(Supplemental Fig. 7) recovered from the multiwavelength optoacoustic data 
generally follow those acquired independently on a UV-Vis plate reader, although 
some discrepancies are observed for IR800 and ICG at shorter wavelengths.   
 We tested in vivo sensitivity and precision for IR800 (Fig. 5). We first 
performed dose escalation studies (n=2). We started injections from 2µM based on 
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the detection limits derived above and assuming ~1:25 dilution of the injected 
contrast agent in the blood stream of the mouse (~100µL injection in ~2.5mL blood 
pool). As expected, there was no enhancement at 2µM, only at 4µM. A clear kinetic 
curve was apparent for 8µM (Fig. 5A), which also gave the best reproducibility in this 
limited study (Fig. 5B). For repeated 8µM injections of in one mouse, a COV of 6.6% 
was derived for the rise above baseline after each injection.       
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DISCUSSION 
Here, we developed and applied a framework that can be used for evaluating 
the precision of OT in phantoms and in vivo (21,22). Data acquired in a stable 
phantom showed exceptional repeatability of the OT system tested, with COV <2% 
across all wavelengths over 30 days. Across all parameters tested, the factors that 
demonstrated greatest impact on the signal repeatability were rotational position and 
ROI drawing by an inexperienced user, which nonetheless produced a COV of less 
than 4%.  
 We explored both repeatability (same subject) and reproducibility (between 
subjects) in vivo. For anatomical data, computed tomography and magnetic 
resonance imaging typically show <5% COV for measurements of ROI size both 
within and between animals (23–25). We found relatively high COVs of 12% and 
18% in the kidney and spleen ROI sizes respectively, when compared across all 
subjects. However, when data were extracted from repeated ROI drawing within the 
same mouse (with replacement), the values fell to 6% and 10% respectively. Our 
findings indicate that the primary source of variation in size is anatomical positioning 
within the non-rigid animal holder. In addition, as contrast is defined by the 
concentration of blood vasculature rather than a clear organ boundary, ROI drawing 
for OT is likely to be more subjective than for a modality like CT.  
We observed a significant drift in functional parameters SO2MSOT and THb 
over 90mins. It has been previously documented that anesthesia induces up to 20% 
change in blood mean hemoglobin concentration (26) and that isoflurane can also 
suppress the erythropoietin hypoxia response and cause vasodilation (27,28), which 
may in part account for the observed drift. The larger effect observed in the spleen 
may be due to the increased hemoglobin concentration of splenic blood, which would 
accentuate these effects (29). The use of water submersion for acoustic coupling 
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may also influence our results, although to the best of our knowledge, the influence 
of external hydrodynamic pressure in mouse hemodynamics has not been quantified. 
These factors may also play in to the longer term drift observed in THb over 3 days; 
further work is necessary to understand the source of this variation. Nonetheless, in 
our SOP we controlled as far as possible for short-term temporal drift by imaging at a 
fixed time point, and for the impact of isoflurane concentration (and associated 
respiration rate) by maintaining consistent values across imaging sessions. Using OT 
to derive SO2MSOT values with our SOP, we found that the COV across mice was 
always <4% and within the same mouse was <2%. For functional oxygenation data 
extracted from blood oxygen level dependent magnetic resonance imaging or arterial 
spin labeling measurements, COVs in the range of 10-15% are often reported 
(30,31). The relatively low COV values measured in our OT system indicate that it 
could be a competitive approach for preclinical functional imaging. 
Finally we examined dye sensitivity and precision in tissue mimicking 
phantoms and in vivo. For IR800, the detection sensitivity limit in phantoms of 100nM 
translated directly into limiting in vivo dose of 4µM based on the expected dilution of 
the injected volume in the blood stream. Performing dye sensitivity studies in tissue 
mimicking phantoms can therefore assist selection of an appropriate dose for in vivo 
studies for untargeted contrast agents. The COV of the signal rise within the kidney 
over repeated injections was 6.6%. For dynamic contrast enhanced magnetic 
resonance imaging, which uses injected gadolinium to assess perfusion and 
permeability, COV in the derived metric Ktrans is typically greater than 10% (24,32). 
Again, our OT system therefore appears competitive for preclinical functional 
imaging. 
There remain some limitations to this study, which was conducted in a single 
center using equipment from a single vendor. In future, multi-center studies across 
multiple vendors would be needed to assess overall precision of OT. It would also be 
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prudent to perform tests over a range of common mouse strains with independent 
physiological measurement, since hemodynamics and skin pigmentation vary 
significantly between strains. For the dye studies, we used a limited number of mice 
and an untargeted contrast agent, which cannot provide insight into the dose 
required for molecular imaging studies where circulatory and cellular barriers must be 
overcome. Such studies should be expanded in future to test targeted contrast 
agents, assessing molecular imaging precision compared to other modalities, for 
example, positron emission tomography (33) and hyperpolarized 13C magnetic 
resonance imaging (34). Future comparison of anatomical, functional and molecular 
imaging measurements made with OT to established preclinical imaging approaches 
will help to establish acceptable performance criteria for OT metrics. 
Nevertheless, we are able to make a number of recommendations based on 
our findings for future studies in vivo using the OT system tested. Firstly, the 
influence of anatomical variation, including biological differences and physical 
(rotational/organ) position on functional metrics can be minimized by extracting the 
ratiometric parameter SO2MSOT. Secondly, both data acquisition and ROI analysis for 
a single study should be performed by users with the same level of experience. 
Finally, an SOP with consistent animal handling and physiology, including a fixed 
duration and concentration range of anesthesia (resulting in stable respiration rate), 
minimizes variation between mice. If these recommendations are followed, the OT 
system tested provides a high precision readout for preclinical imaging. 
CONCLUSION 
We investigated OT precision across key variables including time and user 
experience in phantoms and in vivo. We find that the optoacoustic tomography 
system tested shows performance consistent with or exceeding other reported 
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values for preclinical imaging modalities, highlighting the potential for widespread 
acceptance as a routine tool in preclinical biomedical research in the near future. 
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Figure Legends 
Figure 1. Illustration of system geometry and sample preparation. The sample is 
placed within the imaging chamber using specialized phantom or mouse holders. (A) 
Schematic of the sample holder geometry within the ultrasound transducer ring. (B) 
Photographs of the two holders and their placement in the system. The resulting 
images (C) of the stable polyurethane phantom (top) and mouse cross section 
(bottom) are illustrated with the regions of interest (ROIs) used for signal (including 
kidney and spleen in vivo) and background (bkgd) in the analysis outlined. Scale bar 
=4mm. 
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Figure 2. Optoacoustic precision as a function of time in the stable 
polyurethane phantom at 700nm. (A) Normalized mean pixel intensity over 
160mins (NR) with slope of (-6.34±1.62)x10-5a.u. (B) Mean pixel intensity (arbitrary 
units, a.u) over 6h in a single day with replacement (R) and without replacement 
(NR) of the phantom between data acquisitions; slopes are (-30.7±28.2)a.u. and (-
4.9±29.2)a.u. respectively. (C) Mean pixel intensity over 30 days (R) with a slope of 
(50.4±4.0)a.u., equating to a 0.17% drift. Data were extracted from the signal ROI 
and represent an average of n=5 scan positions per time point. Replacement 
indicates removal of the phantom from the imaging system between measurements; 
average SNR for replacement data was 239±24 and 234±12 for 6h and 30 days 
respectively. Error bars are within the symbols.  
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Figure 3. Impact of sample orientation within the imaging chamber. (A) 
Reconstructed images of the stable polyurethane phantom four different rotations (0, 
90, 180, 270°) reconstructed without impulse response correction. The white lines 
indicate the location of the ultrasound transducer array. Mean pixel intensities from 
an ROI placed over the larger calibration target (signal ROI in Fig. 1C) were 
extracted without (B) and with (C) impulse response correction. Data in (B,C) 
represent an average of n=5 scan positions, with error bars showing the standard 
error on the mean. The SNR (measured across all positions with a background ROI 
placed at the phantom center) increased after impulse response correction, rising 
from 46.1 to 91.5. Scale bar =4mm. 
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Figure 4. Optoacoustic precision as a function of time in vivo. Repeatability for 
in vivo studies was assessed over 90mins (as a representative single scan time), 6 
consecutive replacements (to assess influence of positioning) and over 3 days 
(mimicking a longitudinal study). (A) Oxygen saturation (SO2MSOT) and total 
hemoglobin (THb) measured over 90mins [n=3 mice; SO2MSOT slope=-(9.5±1.9)x10-
4%min-1 left kidney, -(12±1.4)x10-4%min-1 spleen; THb slope=-(30.81±3.05)x10-
4a.u.min-1 left kidney, -(143.8±11.78)x10-3a.u. min-1 spleen]. (B) Over 6 replacements 
little variation was seen [n=7 mice; SO2MSOT slope=(30.4±9.95)x10-4%, left kidney, 
(17.3±6.10)x10-4% spleen; THb slope=(0.02±0.03)a.u. left kidney, (0.13±0.08)a.u. 
spleen]. (C) SO2MSOT was also relatively stable over 3 days, but greater variation was 
seen in THb [n=3 mice; SO2MSOT slope=(18.9±1.2)x10-3%day-1 left kidney, 
(37.6±27.54)x10-3%day-1 spleen; THb slope=(1.2±0.5)a.u.day-1 left kidney, (-4.5±0.6) 
a.u.day-1 spleen]. According to regression analysis, linear fits in B (SO2MSOT and THb) 
and C (SO2MSOT only), are not ‘significantly non zero’, indicating that no systematic 
variation can be observed in these data. Error bars are within the symbols unless 
visible within the graph. 
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Figure 5. Sensitivity and precision for in vivo imaging of IR800CW. Dose 
escalation study of injection of 100µL IR800 at concentrations of 4, 8, 20 and 50µM 
using an ROI drawn on the right kidney of two separate mice (A). Injections were 
made sequentially at 11min intervals and data are time and intensity shifted to show 
the point of injection at t=0min. 8µM was identified as ideal for in vivo visualization 
(B), as only a small enhancement was seen at 4µM. Images in (B) are pre-injection 
(left) and at 1min post-injection (right). White arrows indicate contrast agent inflow 
within the kidneys; scale bar is 3 mm. Mean pixel intensity for 3 repeated injections at 
16min intervals of the same concentration and volume are also shown. 
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Tables 
Table 1: Assessing reproducibility (between mice) using the coefficient of 
variation (COV) of the oxy- (HbO2) and deoxyhemoglobin (Hb) signals 
compared to oxygen saturation (SO2MSOT). COV is of the ROI mean extracted from 
7 mice.  
 
Organ ROI 
Coefficient of Variation (%) 
HbO2 
 
Hb          THb  
 
(HbO2 + Hb) 
      SO2MSOT 
 
HbO2/(HbO2+Hb) 
Spleen 16.4 13.8 12.9 3.9 
Kidney 18.0 18.4 17.2 3.4 
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Table 2: Assessing the influence of animal preparation and stability in the 
chamber on the coefficient of variation (COV) of oxygen saturation (SO2MSOT). 
‘Per mouse, with replacement’ is the average COV calculated over 6 image frames 
acquired per mouse imaged by a single experienced user with replacement i.e. 
mouse removed from the imaging chamber in between measurements (n=4 refers to 
the 4 replicates of the experiment). ‘Per mouse, no replacement’ is the average COV 
calculated from 6 image frames acquired per mouse without replacement by a single 
experienced user (n=4) and a second inexperienced user (n=3). The average COV 
over the total n=7 replicates is also given. Error bars represent the standard error on 
the mean. 
 
Organ 
ROI 
Coefficient of Variation (%) 
Per Mouse, 
With Replacement 
 Per Mouse 
No Replacement 
(1 experienced 
user, n=4) 
 (1 experienced 
user, n=4) 
(1 inexperienced 
user, n=3) 
(2 users, 
n=7) 
Spleen 1.35±0.34  0.54±0.08 0.79±0.16 0.76±0.29 
Kidney 1.02±0.15  0.34±0.05 0.64±0.07 0.47±0.18 
 
 
 
